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Background: The statutory health insurance system embodies a large amount of data on the treatments of their
members. Depending on joint, prosthesis type, patient activity and comorbidity, knee and hip replacements can last
up to 20 years. Based on statutory health insurance data the main object of this analysis was to investigate how
high the early revision rate of replacements actually is.
Methods: The number of replacements in the years 2005 and 2006 has been extracted from the TK database for
hip (OPS-Code 5-820, n = 20,875), knee (OPS 5-822, n = 13,466), upper limbs (OPS 5-824, n = 901), and lower limbs
(OPS 5-826) replacements. This data has then been related to each consecutive operation (i. e. change or excision
of joint endoprosthesis) over a joint-specific observation period of two years.
Results: In 3.7% of the cases joint replacements stood for less than 2 years (hip 3.5%, knee 3.8%, upper limbs 6.5%,
and lower limbs 5.5%). There is a significantly positive correlation between the treatment data of the hospitals and
the outcome as to low rates of reoperations at early stages. The main reason for short lifetime (76 - 81%) is
mechanical failure.
Conclusion: The percentage of joint endoprostheses with significantly short lifetimes has been unexpectedly high.
The de facto lifetimes of joint endoprostheses thus often do not match the manufacturers’ information. The authors
strongly support the idea of a national endoprosthesis register as such a register could give detailed information on
• firstly whether these deficits are due to material defects, osteolysis or dislocation and
• secondly which products are mainly affected.
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Manufacturers specify that the lifetimes of joint endo-
prostheses, i. e. the time between first operation and the
first reoperation, is 15 years and above. However, joint
endoprostheses often fail before that. Among others, the
two main reasons are material defects or faulty construc-
tions as was frequently published in the press with high
circulation last year [1-3]. In March 2010, a hospital had* Correspondence: prof.dr.roland.linder@wineg.de
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reproduction in any medium, provided the orto change 125 defect hip prostheses because cuttings of
a special type of hip endoprostheses detached [4].
A change of joint endoprosthesis is indicated in case
of aseptic or septic loosening, periprosthetic fracture
caused by a trauma or material defects. Progressive attri-
tion in the joint parts not yet replaced (e.g. partial
replacement of knee joints) or major functional impair-
ment after joint replacement may also indicate a change.
For a detailed list of relevant complications see Saleh
et al. 2002 [5]. Recently Anand et al. published a survey
on the market penetration and performance of newly
introduced hip and knee prostheses. Between 2003
and 2007 266 new hip or knee endoprostheses wereLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of the new knee prostheses and a fifth of the new hip
prostheses came to use in more than 100 procedures
and were subject to evaluation. Roughly a third of the
new prostheses showed higher revision rates than well
established models [6].
According to the figures published in the BQS quality
reportsa in 2004 a total number of 137,858 primary hip
replacements and 17,696 revision hip arthroplasties were
carried out [7]. In 2008 these figures rose to 156,803 pri-
mary hip replacements and 22,628 revision hip arthro-
plasties [8]. The number of primary hip arthroplasties
increased by 13.7%, whereas the revision hip arthroplas-
ties rose by double (27.9%), see Tables 1 and 2.
A precise analysis of these findings is impossible, due
to the limitations of the data available. Neither the data
transferred to the statutory health insurance funds nor
the data collected by the BQS contains the needed infor-
mation about the precise type of prosthesis. The follow-
up data is also limited: the observation horizon either
ends with hospital demission of the patient (data of the
BQS) or when the patient changes the statutory health
insurance fund (the statutory health insurance data).
Material defects may cause serial defects which can
result in a large number of failures concerning one prod-
uct. A mechanical defect - e. g. a founding fault - can
lead to the break of a large number of implants. For
example a specific series of hip joint components of an
US manufacturer loosened early because of lubricant
residues on the surface of the components in 2000.
According to press reports 5,500 to 6,000 prostheses of
the withdrawn surface replacing prosthesis “ASR” of the
DePuy Company have been implanted [9,10]. Exact fig-
ures are not available, since a central national register
for joint replacement does not exist yet. Therefore cur-
rently the only way to investigate the specific research
questions is by using intersectoral data of a large nation-
wide statutory health insurance fund covering several
millions of insurants.
Methods
The data analysed, consists of patient specific data which
have to be transferred from the hospital to the health in-
surance funds for every inpatient treatment. The data
comprise different items, i.e. age, sex, date of hospital
admittance, diagnosis, treatment, reimbursement code
etc. as well as identification numbers which allows forTable 1 Development of primary total hip arthroplasty and h







137,858 17,696 156,803individual patient follow-up. Initially data is collected for
payment procedures. Since all data have been anon-
ymised and since exclusively aggregated statistics have
been generated, there is no need to ask for an ethic
approval. The focus was set on the diagnosis and treat-
ment codes (ICD10-GM and OPS), of patients who had
continuously been insured with the TK from 2005-01-01
to 2009-12-31. The OPS is the German Procedure Clas-
sification published by the German Institute for Medical
Documentation and Information (DIMDI; “Deutsches
Institut für Medizinische Dokumentation und Informa-
tion”). The ICD10-GM, the German Modification of the
International Classification of Diseases and Related
Health Disorders, used are from the catalogue versions
of the year in question. The focus was set on the three-
figure OPS 5-82 (endoprosthetic replacement of joint
and bone) in comparison with the four-figure OPS for
implantation of joint endoprostheses 5-820 (hip), 5-822
(knee), 5-824 (joints of the upper limbs: shoulder, elbow,
wrist, and finger arthroplasty), and 5-826 (joints of the
lower limbs: ankle, forefoot, and toe arthroplasty) as well
as the corresponding revisions which lead to a replace-
ment or removal of joint endoprostheses (5-821, 5-823,
5-825, and 5-827). Revisions which left the implant
unchanged were not taken into consideration (5-821.0,
5-823.0, 5-825.0, and 5-827.0). The following ICD-codes
were evaluated for the purpose of causal research:
figures T 84.0 and T 84.4 combined as “mechanical
complications”, figures T 84.0 and T 84.7 combined as
“infection/inflammation”, as well as figures T 84.8
(“other complications”) and T 84.9 (“complications not
exactly specified”).
Joint endoprostheses implantations between 2005-01-
01 and 2007-12-31 were identified under the assumption
of being primary implantations. The only inclusion cri-
teria were the aforementioned OPS-codes. Exclusion cri-
teria have not been applied. Based on the relevant
operation date the corresponding patient was being
monitored over a period of two years. New operations
in terms of repeated changes of implants or new implan-
tations after removal of the former prosthesis were
not taken into consideration. The observation period
of two years for short-term reoperations equals the period
which is the indicator of “short-term complications”. This
indicator is included as national quality indicator in the re-
port “Quality and Efficiency in Swedish Health Care.
Regional Comparisons 2007” of the Swedish Associationip revision surgery 2004-2008 [7,8]








Table 2 Development of primary total knee arthroplasty and knee revision surgery 2004-2008 [7,8]













110,349 7,238 145,996 10,376 +32.6 +43.4
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National Board of Health and Welfare, SoS [11,12].
The two-tailed Mann–Whitney-U-Test was applied to
the comparative examination between patients with and
without short-term reoperations, between hospitals with
and without a defined minimum number of operations
per year, and hospitals with and without an integrated
health care contract with the statutory health insurance
fund Techniker Krankenkasse, furthermore referred to
as TK, respectively. Regarding hospital procedure
volumes a threshold of 100 operations annually has been
chosen because this threshold has already been used by
Katz et al. in their prominent study on the association
between procedure volumes and outcomes [13]. Subse-
quently this has been adopted by the German Society for
Orthopaedics and Orthopaedic Surgery and the German
company ClarCert in Neu-Ulm who jointly developed a
concept for attesting centres specialised on endoprosth-
eses operations. From an expert point of view a thresh-
old of 100 is feasible and scientifically adequate.
The significance level was set at 0.05. Finally 4-figure
and 5-figure OPS have been listed with the aggregation
of (normally 6-figure) OPS-figures without indicating a
possible more detailed specification.Results
5,027,709 individuals were insured at TK during the ob-
servation period from 2005-01-01 until 2007-12-31.
Within the observation period the population received a
total of 20,875 hip replacements, moreover 13,466 total
knee replacements, 901 upper limb endoprostheses, 128
lower limb endoprostheses (for demographics see
Table 3). The percentage of short-term reoperations of
hip endoprostheses amounted to 3.47% (knee 3.81%,Table 3 Distribution on sex and age
Location Sex Median age Age range
Total hip replacement m 68 16 - 100
(n = 20,875) f 69 15 - 104
Total knee replacement m 69 15 - 97
(n = 13,466) f 69 12 - 95
Upper limb endoprosthesis m 66 14 - 91
(n = 901) f 70 23 - 96
Lower limb endoprosthesis m 64 27 - 82
(n = 128) f 61 28 - 79upper limb 6.55%, and lower limb 5.47%) during the two
years of postoperative observation.
Over the whole period of two years the percentage
of mechanical complications regarding all four joint
localisations amounted from 76% to 81% as to the total
number of reoperations, the rate of infections and
inflammations amounted from 18% to 19%. A significant
difference between the joint localisations is not evident.
Concerning hips, the index surgery most often leading
to revision are 5-820.5 (acetabular revision cup/cage sys-
tems 29.2%), 5-820.7 (snap-fit acetabular cup12.5%), and
5-820.3 (femoral head prosthesis 5.7%).
Regarding knees, the index surgery most frequently
effecting revision are 5-822.0 (uni-compartmental knee
9.0%), 5-822.x (other endoprostheses 7.5%), and 5-822.b
(endoprostheses with extended flexor capability and pa-
tella supplementation 6.3%). The OPS-code 5-822.b was
first listed in the OPS version of 2007.
The relation between the annual number of cases of
joint replacement surgery per institution and the rate of
short-term reoperations (see Figures 1 and 2, as well as
Tables 4 and 5) shows a negative correlation for a level
of 100. There is a highly significant difference between
the rates of reoperations at clinics. The latter perform more
than 100 primary implantations (p < 0.001) of both hips
and knees. It is important to emphasise that rates of short-
term reoperations listed in Tables 4 and 5 are higher than
the values given above. This is probably a consequence of a
couple of large hospitals which are of outstanding quality.
For instance, the top three hospitals in terms of procedure
volumes yield 1.9% as a rate of short-term reoperations
regarding hip joints (knee endoprostheses 2.8%).
The patients’ age in facilities with a proportion of
short-term reoperations ≥ 20% was compared to the
patients’ age in other facilities with better outcome to
ensure that patients are considered from facilities with
various complication rates. For instance, older patients
(who are thus more often ill) are treated in smaller insti-
tutions close to their homes. Significant differences as to
joints of hip or knee are not apparent (p = 0.990 and p =
0.766, respectively).
Considering short-term complications as a quality
indicator like the Swedes do (as mentioned before), hos-
pitals with integrated health care contracts with TK for
endoprosthetic care have by tendency a high quality
treatment as to the rate of short-term reoperations (hip:
p = 0.121, knee: p = 0.132), see Figures 1 and 2.
Figure 1 Scatter plot: Each circle stands for a hospital. Its area correlates with the number of hip joint endoprostheses implantations of the
persons insured at TK. The abscissa shows the annual number of cases according to BQS [7]. Those hospitals with integrated health care contracts
with TK for endoprosthetic care are marked in red.
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basis of statutory health insurance routine data (not illu-
strated). They relate the OPS-codes of initial operations
to the OPS-codes of early reoperations. Possible add-
itional dimensions of such a matrix are: the definition of
the primary disease at time of implantation (osteoarthro-
sis, rheumatoid arthritis, fractures close to joint), the dis-
tinction between cemented and non-cemented implants
(6th position of OPS-code), or the type of complication
which led to the reoperation (mechanical problems or
infections). For instance, total hip replacement (OPS 5-
820.0) with an early subsequent removal of the endo-
prosthesis (OPS 5-821.7) showed to be three times
more induced by infections (ICD T84.5 and T84.7) than
by mechanical complications (ICD T84.0 and T84.4).
The age distribution of patients with short-term reopera-
tions was compared with that of patients without short-
term reoperations to check whether implantations in
older patients were less carefully executed than in
younger ones. Significant differences did not arise with
hip endoprostheses (patients with short-term reopera-
tion: median age = 67 years, patients without short-term
reoperation: = 67 years, p = 0.533). A significant differ-
ence of p < 0.001 occurred, though, for knee endoprosth-
eses. The median age of 67 for patients with short-termreoperation is one year below the median age of the
reference group (median age = 68 years).
Discussion
Due to the increase in musculoskeletal disorders of an
aging population the World Health Organization
(WHO) and the United Nations (UN) have declared the
years 2000 to 2010 as to be the “Bone and Joint Decade”.
In the beginning of the next decade, the booming supply
of endoprostheses will still be a major issue. The large
number [14] as well as the combination varieties of new
prostheses modules urgently requires a quality ensuring
joint replacement register.
Result Discussion
Comparing accounting data and statutory health insur-
ance data with registry data has limitations. The patient
relevant outcome (time between primary implantation
and revision surgery), however, can be extracted from
both data sets and it is possible to compare these values.
Comparing the present findings with data from the
Swedish Hip Arthroplasty Register [12], one finds signifi-
cantly smaller early revision rates than in the population
of TK insurants. In this context the average early revi-
sion rate between 2005 and 2008 is 1.6% with a county
Figure 2 Scatter plot as in Figure 1 but for knee endoprosthetic joint implantations.
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comparison with the data of AOK (Local Health Care
Fund in Germany) shows similar complication rates within
an observation period of one year after hip endoprosthesis
with coxarthrosis (2.8%), hip endoprosthesis with hip frac-
ture (3.8%), and after knee endoprosthesis (1.7%) [15].
Most prostheses loosenings are due to aseptic loosen-
ings according to the results published by BQS [8]. This
can be attributed to local inflammatory reactions of tissue
to micro wear particles of the prosthesis material or bony
transformation as reaction to a changed mechanical situ-
ation. This result has also been internationally reported
(Sweden [16], Australia [17], England/Wales [18]).
Regarding possible differences in age distribution of
patients with and without short-term reoperation, it can-
not be concluded that the reason is increased exposure
of younger patients’ endoprostheses or rather the lack ofTable 4 Differences between hospitals with low and high pro
Number of hip joint endoprostheses
implantations of the persons
insured at TK
Rate of short-term reoper
hospitals with < 100 oper
p.a. (%, median)
< 10 20.0 (44 hospitals)
10 - 19 10.0 (19 hospitals)
> = 20 4.76 (5 hospitals)
Total 14.3 (68 hospitals)
Number of hip joint endoprostheses of the persons insured at TK serves as an indica possible surgery due to medical reasons or the less fre-
quent wish of older patients to be reoperated.
Considering the top three index surgeries most often
leading to revision, knee prosthesis designed for higher
flexion (high-flex knees, OPS 5-822.b) is of special inter-
est: The findings presented support the findings of
Hamilton et al. [19] that high flex knee prosthesis shows
a higher risk of early loosening. Endres [20] has shown
that patients with high-flex knee prosthesis achieve no
better range of motion than patients with usual knee
prosthesis. It can be concluded that the patient related
benefit of high-flex knee prosthesis is at least unclear,
presumably not existent, but exposes the patient to a
higher risk of earlier revision.
The Institute for Quality and Efficiency in Statutory Health
Insurance, furthermore referred to as IQWiG (“Institut für
Qualität und Wirtschaftlichkeit im Gesundheitswesen”)cedure volumes (threshold = 100 operations annually)
ations in
ations
Rate of short-term reoperations in
hospitals with > = 100 operations
p.a. (%, median)
p value
14.3 (32 hospitals) 0.070
7.7 (72 hospitals) 0.111
4.2 (211 hospitals) 0.304
5.7 (315 hospitals) < 0.001
ator for confidence.
Table 5 Differences between hospitals with low and high procedure volumes (threshold = 100 operations annually)
Number of knee joint endoprostheses
implantations of the persons
insured at TK
Rate of short-term reoperations in
hospitals with < 100 operations
p.a. (%, median)
Rate of short-term reoperations in
hospitals with > = 100 operations
p.a. (%, median)
p value
< 10 22.2 (47 hospitals) 16.7 (24 hospitals) 0.229
10 - 19 9.1 (31 hospitals) 8.3 (54 hospitals) 0.481
> = 20 8.2 (10 hospitals) 4.8 (136 hospitals) 0.058
Total 14.3 (88 hospitals) 6.6 (214 hospitals) < 0.001
Number of knee joint endoprostheses of the persons insured at TK serves as an indicator for confidence.
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identified a U-shaped course between the number of cases
and the risk for complications considering knee endo-
prostheses [21]. Instead of the frequency of short-term
reoperations the risk of a restricted postoperative joint
mobility and postoperative wound infection has been ana-
lysed. These IQWiG results do not contradict the results
presented in this publication. However, it is not the aim of
the authors to foster the challenging discussion on mini-
mum quantities [22,23]. Instead, the authors would like to
put emphasis on quality indicators in order to evaluate the
success of treatment. The former are currently gaining im-
portance in the context of selective contracts for inte-
grated care, gatekeeper centred health care and disease
managements programmes [24].
Limitations and strengths
The Techniker Krankenkasse has more than 8 million
insurants representing approximately 10 percent of the
inhabitants of the federal Republic of Germany. At TK,
the sample analysed is a full sample and therefore repre-
sentative for TK insurants. However, characteristics of
the specific characteristics of TK insurants may differ
from the entire German population e.g. regarding the
socio-economic status and thereby the BMI that on his
part may influence the rate of short-term reoperations.
Unfortunately, with exception of somewhat additional
documentation like for participants in disease manage-
ment programs, there is no possibility to control con-
founders. Therefore it will be not allowed to extrapolate
the results to the entire population.
The authors would have preferred to apply other qual-
ity indicators such as the “ten-year prosthesis survival”
used by SALAR and SOS [11] but the localisation char-
acters “R” (right sided), “L” (left sided), or “B” (both
sides) relevant for the implant classification has only
been documented since 2005-01-01.
The data on both hip and knee endoprostheses com-
prised more than 34,000 total joint replacements includ-
ing follow-up and was thus comprehensible enough.
Between 2005 and 2007 endoprostheses for shoulder,
ankle, or elbow were so seldom implanted that reliable
data to the joints of upper and lower limbs do not
yet exist.The assumption is that the de facto percentage of
short-term complications will be higher than reported,
since inoperable patients, the deceased and those who
change their statutory health insurance fund have not
been considered. Please note that the reported figure for
primary implantations cannot be used for epidemio-
logical information: On the one hand, the TK insurants
differ from the total population of insurants in German
statutory health insurance funds. On the other hand the
complex primary implantations which are separately to
encode (OPS 5-829.a) were just not considered as such
as the use of tumour endoprostheses (OPS 5-829.c) or
hypoallergenic prostheses (OPS 5-829.e). The OPS-
catalogue has been adjusted several times during the
observation period of primary implantations. The OPS
5-820.6 (femoral head) has been abandoned with the
OPS-catalogue 2007 introducing the OPS 5-820.8 (hip
resurfacing). The OPS 5-820.9 (neck-conserving femoral
head prosthesis) used in the current OPS-catalogue 2010
was not evaluated since it has only been introduced with
the OPS-catalogue 2008.
Outlook
In addition to reoperations it is without doubt necessary
to investigate re-reoperations, thus following the Swedish
example [12]. Moreover it would be enriching not only
to focus on complications, but to consider all others
medical services demanded in the context of the
treatment. The data of statutory health insurance funds
for example offers valuable data on post-hospital re-
habilitation [25] or ambulatory care, physiotherapy and
further medication. It also includes the ICD-codes not
only of the primary diseases (e.g. coxarthrosis or
rheumatoid arthritis) but also of the relevant comorbid-
ities. In contrast to the options of the aggregated short-
term information of hospitals transferred to the BQS
the data of the statutory health insurance funds allows
morbidity-orientated matching and benchmarking. Fur-
thermore reoperation data can also be referred to the
ICD-codes for injuries or periprosthetic fractures (ICD
S72, S82). An overall analysis of joint replacement and
all other related medical services would generate find-
ings of the complete picture. Evaluation of statutory
health insurance data will always have limitations (e.g.
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subjectiveness of patient evaluation or deficits in docu-
mentation). Nevertheless this data will deliver valuable,
new findings on joint replacements and further research
questions, especially when connected to register data.
Arthroplasty register
Hardly anybody doubts the medical necessity of a high
quality arthroplasty register [26,27]. It is the basis for
callbacks as known from the car industry where it is
possible to unambiguously allocate vehicles to owners.
An arthroplasty register will lead to valid revision rates
which are four to fourteen times underestimated in clin-
ical literature [28]. And last but not least an arthroplasty
register is highly interesting regarding economic aspects:
The German Society for Orthopaedics and Orthopaedic
Surgery, (DGOOC, “Deutsche Gesellschaft für Orthopädie
und Orthopädische Chirurgie”) reckons savings of 45 mil-
lion Euro in the third year of the register. In contrast, add-
itional costs of the register will be distinctly less [29].
A joint replacement register must necessarily have an
implant to patient allocation and could usefully be supple-
mented by selected statutory health insurance routine
data.
Conclusions
Our analysis shows quality deficits in joint replacements.
The current state of joint replacement in Germany con-
tradicts the German social legislation which calls for a
highly qualified service according to the current state of
scientific and medical knowledge. A national arthro-
plasty register could help to detect problems at a very
early stage as it monitors the service providers and med-
ical products under daily conditions. This has already
been proven in other countries. It is time to give
German patients and physicians equal opportunities,
better treatment options and avoid avoidable damage.
Endnote
aBQS (“Institut für Qualität und Patientensicherheit -
Bundesgeschäftsstelle Qualitätssicherung GmbH”) is a
non-profit organisation which was commissioned to be
in charge of the quality assurance of the German hospi-
tals from 2001 to 2009. BQS was commissioned by the
umbrella organisation of the statutory health insurance
funds (“Spitzenverbände der gesetzlichen Krankenkas-
sen”) together with the Central Association of Private
Health Insurance (“Verband der privaten Krankenversi-
cherung”), the German Hospital Federation (“Deutsche
Krankenhausgesellschaft”), the German Medical Asso-
ciation (“Bundesärztekammer”) and the German Care
Council (“Deutscher Pflegerat”). As a result of a tender-
ing procedure the Institute for Applied Quality Improve-
ment and Research in Health Care (“AQUA-Insitutfür angewandte Qualitätsförderung und Forschung im
Gesundheitswesen GmbH”) has undertaken this task
since 2010.
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